574 related articles for article (PubMed ID: 17604034)
21. Priming of CD8+ T cell responses following immunization with heat-killed Plasmodium sporozoites.
Hafalla JC; Rai U; Morrot A; Bernal-Rubio D; Zavala F; Rodriguez A
Eur J Immunol; 2006 May; 36(5):1179-86. PubMed ID: 16598821
[TBL] [Abstract][Full Text] [Related]
22. Genetically attenuated Plasmodium berghei liver stages persist and elicit sterile protection primarily via CD8 T cells.
Mueller AK; Deckert M; Heiss K; Goetz K; Matuschewski K; Schlüter D
Am J Pathol; 2007 Jul; 171(1):107-15. PubMed ID: 17591958
[TBL] [Abstract][Full Text] [Related]
23. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
24. An early commitment to expression of a particular TCRVbeta chain on CD8(+) T cells responding to attenuated Plasmodium berghei sporozoites is maintained following challenge with infectious sporozoites.
Lumsden JM; Cranmer MA; Krzych U
Parasite Immunol; 2010; 32(9-10):644-55. PubMed ID: 20691016
[TBL] [Abstract][Full Text] [Related]
25. Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.
Purcell LA; Wong KA; Yanow SK; Lee M; Spithill TW; Rodriguez A
Vaccine; 2008 Sep; 26(38):4880-4. PubMed ID: 18672017
[TBL] [Abstract][Full Text] [Related]
26. Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites.
Butler NS; Schmidt NW; Vaughan AM; Aly AS; Kappe SH; Harty JT
Cell Host Microbe; 2011 Jun; 9(6):451-62. PubMed ID: 21669394
[TBL] [Abstract][Full Text] [Related]
27. Parasitology. Malaria vaccines: back to the future?
Waters AP; Mota MM; van Dijk MR; Janse CJ
Science; 2005 Jan; 307(5709):528-30. PubMed ID: 15681372
[No Abstract] [Full Text] [Related]
28. Assessing the adequacy of attenuation of genetically modified malaria parasite vaccine candidates.
Annoura T; Ploemen IH; van Schaijk BC; Sajid M; Vos MW; van Gemert GJ; Chevalley-Maurel S; Franke-Fayard BM; Hermsen CC; Gego A; Franetich JF; Mazier D; Hoffman SL; Janse CJ; Sauerwein RW; Khan SM
Vaccine; 2012 Mar; 30(16):2662-70. PubMed ID: 22342550
[TBL] [Abstract][Full Text] [Related]
29. Plasmodium berghei sporozoite challenge of vaccinated BALB/c mice leads to the induction of humoral immunity and improved function of CD8(+) memory T cells.
Tartz S; Deschermeier C; Retzlaff S; Heussler V; Sebo P; Fleischer B; Jacobs T
Eur J Immunol; 2013 Mar; 43(3):693-704. PubMed ID: 23229763
[TBL] [Abstract][Full Text] [Related]
30. Do apoptotic Plasmodium-infected hepatocytes initiate protective immune responses?
Renia L; Maranon C; Hosmalin A; Gruner AC; Silvie O; Snounou G
J Infect Dis; 2006 Jan; 193(1):163-4; author reply 164-5. PubMed ID: 16323145
[No Abstract] [Full Text] [Related]
31. Intradermal immunization of mice with radiation-attenuated sporozoites of Plasmodium yoelii induces effective protective immunity.
Voza T; Kebaier C; Vanderberg JP
Malar J; 2010 Dec; 9():362. PubMed ID: 21159170
[TBL] [Abstract][Full Text] [Related]
32. Immunization with a circumsporozoite epitope fused to Bordetella pertussis adenylate cyclase in conjunction with cytotoxic T-lymphocyte-associated antigen 4 blockade confers protection against Plasmodium berghei liver-stage malaria.
Tartz S; Kamanova J; Simsova M; Sebo P; Bolte S; Heussler V; Fleischer B; Jacobs T
Infect Immun; 2006 Apr; 74(4):2277-85. PubMed ID: 16552058
[TBL] [Abstract][Full Text] [Related]
33. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
[TBL] [Abstract][Full Text] [Related]
34. Liver or blood-stage arrest during malaria sporozoite immunization: the later the better?
Nganou-Makamdop K; Sauerwein RW
Trends Parasitol; 2013 Jun; 29(6):304-10. PubMed ID: 23608185
[TBL] [Abstract][Full Text] [Related]
35. Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites.
Mauduit M; Tewari R; Depinay N; Kayibanda M; Lallemand E; Chavatte JM; Snounou G; Rénia L; Grüner AC
Infect Immun; 2010 May; 78(5):2182-8. PubMed ID: 20194600
[TBL] [Abstract][Full Text] [Related]
36. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites.
Leitner WW; Seguin MC; Ballou WR; Seitz JP; Schultz AM; Sheehy MJ; Lyon JA
J Immunol; 1997 Dec; 159(12):6112-9. PubMed ID: 9550412
[TBL] [Abstract][Full Text] [Related]
37. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.
Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA
J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760
[TBL] [Abstract][Full Text] [Related]
38. Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite protein vaccines. Overcoming genetic restriction with whole organism and subunit vaccines.
Hoffman SL; Berzofsky JA; Isenbarger D; Zeltser E; Majarian WR; Gross M; Ballou WR
J Immunol; 1989 May; 142(10):3581-4. PubMed ID: 2497175
[TBL] [Abstract][Full Text] [Related]
39. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites.
Kumar KA; Sano G; Boscardin S; Nussenzweig RS; Nussenzweig MC; Zavala F; Nussenzweig V
Nature; 2006 Dec; 444(7121):937-40. PubMed ID: 17151604
[TBL] [Abstract][Full Text] [Related]
40. Genetically modified Plasmodium highlights the potential of whole parasite vaccine strategies.
Good MF
Trends Immunol; 2005 Jun; 26(6):295-7. PubMed ID: 15922944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
